Q4 2017 Holdings
Filed 2018-02-14 | 39 holdings | $32.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.6M | 163,997 | 44.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.0M | 86,293 | 33.6% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $3.8M | 179,870 | 11.6% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $2.7M | 41,905 | 8.3% |
| Spdr S&P Biotech ETF(XBI)Put | S&P BIOTECH | 78464A870 | $169.7K | 2,000,000 | 0.5% |
| Allergan PLC | SHS | G0177J108 | $34.0K | 207,871 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $25.1K | 161,949 | 0.1% |
| Mylan NV | SHS EURO | N59465109 | $19.9K | 470,296 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $19.5K | 346,293 | 0.1% |
| Bristol-Myers Squibb Co(BMY)Call | COM | 110122108 | $18.1K | 295,600 | 0.1% |
| AstraZeneca PLC(AZN)Call | SPONSORED ADR | 046353108 | $16.2K | 466,600 | 0.0% |
| Ablynx NV | SPONSORED ADR | 00372Y105 | $15.9K | 637,884 | 0.0% |
| Clovis Oncology Inc(CLVSEUR)Call | COM | 189464100 | $15.9K | 233,200 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.6K | 498,921 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $13.0K | 453,032 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $12.3K | 311,516 | 0.0% |
| Flexion Therapeutics IncCall | COM | 33938J106 | $11.7K | 466,500 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $11.6K | 708,544 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $9.5K | 200,841 | 0.0% |
| BioMarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $9.2K | 103,600 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.2K | 55,834 | 0.0% |
| Sucampo Pharmaceuticals Inc | CL A | 864909106 | $9.2K | 510,486 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $8.7K | 72,400 | 0.0% |
| GlycoMimetics Inc(GLYCEUR) | COM | 38000Q102 | $8.1K | 480,442 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $7.6K | 925,327 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.8K | 445,550 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.5K | 404,528 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $5.2K | 286,647 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.9K | 536,568 | 0.0% |
| Spectrum Pharmaceuticals IncPut | COM | 84763A108 | $4.9K | 259,300 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $4.2K | 311,175 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.1K | 505,921 | 0.0% |
| Tesaro IncPut | COM | 881569107 | $4.1K | 50,000 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $3.3K | 602,748 | 0.0% |
| TherapeuticsMD Inc | COM | 88338N107 | $3.2K | 528,351 | 0.0% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8K | 180,794 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $792 | 171,435 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $246 | 30,000 | 0.0% |
| VistaGen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $154 | 138,132 | 0.0% |